The four drugs
Key facts
- Isoniazid blocks mycolic acid synthesis once the mycobacterial enzyme KatG has switched it on.
- Rifampicin kills by blocking RNA polymerase, and resistance emerges fast when it's used alone.
- Pyrazinamide acts in acidic lesions and macrophages; ethambutol blocks arabinosyl transferase.
Each drug has its own target in the organism. Isoniazid and ethambutol stop the cell wall being built, rifampicin stops RNA being made, and pyrazinamide acts on an enzyme the organism needs to make coenzyme A.
Isoniazid
- How it works
- A prodrug switched on by a mycobacterial enzyme, KatG. It then blocks the enzymes that build mycolic acid, so the organism cannot make its wall. Resistance comes from mutation or loss of KatG, or from a change in the target enzyme. Cross-resistance with ethionamide can occur.
- What it acts on
- Rapidly growing bacilli and organisms inside cells. It reaches all body fluids, cells and caseous material.
- Adverse effects and interactions
- Hepatitis, the most serious effect. Risk rises with age, with rifampicin and with daily alcohol. Peripheral neuropathy from relative pyridoxine deficiency, prevented by giving pyridoxine alongside it. Convulsions in those prone to seizures. Inhibits the metabolism of phenytoin and carbamazepine, so their adverse effects grow stronger.
Rifampicin
- How it works
- Bactericidal (it kills the organism). It blocks RNA transcription by binding the beta subunit of mycobacterial DNA-dependent RNA polymerase. Resistance comes from mutations that lower the polymerase's affinity for the drug, and resistant strains emerge rapidly when it is used alone.
- What it acts on
- Organisms inside and outside cells.
- Adverse effects and interactions
- Induces hepatic cytochrome P450 enzymes, so many other drugs are cleared faster. Nausea, vomiting and rash. Orange-red urine, tears and secretions. Tears can permanently stain soft contact lenses. A flu-like illness with intermittent higher doses.
Pyrazinamide
- How it works
- A prodrug. Bacterial pyrazinamidase converts it to pyrazinoic acid, the active form, which binds aspartate decarboxylase (PanD), an enzyme the organism needs to make coenzyme A. Some resistant strains lack pyrazinamidase, so the drug is never converted.
- What it acts on
- Bacilli in acidic lesions and inside macrophages.
- Adverse effects and interactions
- May contribute to hepatotoxicity. Hyperuricaemia is common, but it rarely brings on gout.
Ethambutol
- How it works
- Bacteriostatic (it stops growth without killing). It inhibits arabinosyl transferase, an enzyme that helps build the mycobacterial cell wall.
- What it acts on
- Actively multiplying bacilli, inside and outside cells.
- Adverse effects and interactions
- Optic neuritis: falling visual acuity and loss of red-green discrimination. Risk rises at higher doses and in renal impairment. Decreases uric acid excretion.